Table 2.
Self-reported sleep health, mental health, substance use, and sexual risk behaviors
| % (n) | |
|---|---|
| Sleep quality | |
| Very good | 10.9 (22) |
| Fairly good | 54.5 (110) |
| Fairly bad | 27.7 (56) |
| Very bad | 6.9 (14) |
| Sleep durationa(h) | |
| <5 | 7.9 (16) |
| 5–6 | 35.7 (72) |
| 7–8 | 46.5 (94) |
| >8 | 6.4 (13) |
| Depressive symptoms | |
| Absent | 77.7 (157) |
| Present | 22.3 (45) |
| Alcohol (>5 drinks) | 38.6 (78) |
| Club drugs | 23.3 (47) |
| Ecstasy/MDMA | 14.9 (30) |
| GHB/GBL | 14.9 (30) |
| Ketamine | 4.5 (9) |
| LSD/Acid | 1.0 (2) |
| Cocaine | 14.4 (29) |
| Inhalant nitrites | 36.6 (74) |
| Marijuana | 19.8 (40) |
| Methamphetamine use | 13.9 (28) |
| Insertive anal intercourse | |
| 0 partners | 24.6 (48) |
| ≥1partners | 75.4 (147) |
| Receptive anal intercourse | |
| 0 partners | 34.4 (67) |
| ≥1partners | 65.6 (128) |
| Condomless insertive anal intercourse | |
| 0 partners | 55.0 (111) |
| ≥1partners | 45.0 (91) |
| Condomless receptive anal intercourse | |
| 0 partners | 62.9 (127) |
| ≥1partners | 37.1 (75) |
Abbreviations: MDMA, 3,4-methylenedioxymethamphetamine; GHB/GBL, γ-hydroxybutyric acid/γ-butyrolactone; LSD, lysergic acid diethylamid.
a
Nightly.